126 related articles for article (PubMed ID: 4054071)
1. Plasma fibrinolysis after intraduodenal administration of urokinase in rats.
Sumi H; Seiki M; Morimoto N; Tsushima H; Maruyama M; Mihara H
Enzyme; 1985; 33(3):122-7. PubMed ID: 4054071
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-like plasminogen activator increased in plasma after alcohol drinking.
Sumi H; Hamada H; Tsushima H; Mihara H
Alcohol Alcohol; 1988; 23(1):33-43. PubMed ID: 3128990
[TBL] [Abstract][Full Text] [Related]
3. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
[TBL] [Abstract][Full Text] [Related]
4. Activation of plasma fibrinolysis after intrarectal administration of high molecular weight urokinase and its derivative.
Sumi H; Maruyama M; Yoneta T; Mihara H
Acta Haematol; 1983; 70(5):289-95. PubMed ID: 6414221
[TBL] [Abstract][Full Text] [Related]
5. Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis.
Abe T
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):122-36. PubMed ID: 2427393
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
7. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--IV. Variability in fibrinolytic response of plasma of several mammalian species.
Lijnen HR; De Wreede K; Demarsin E; Collen D
Thromb Haemost; 1984 Aug; 52(1):31-3. PubMed ID: 6495261
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the activity of high and low molecular weight urokinase in the presence of fibrin.
Samama M; Castel M; Matsuo O; Hoylaerts M; Lijnen HR
Thromb Haemost; 1982 Feb; 47(1):36-40. PubMed ID: 7041325
[TBL] [Abstract][Full Text] [Related]
9. The biphasic nature and temperature dependence of the activation of human plasminogen by urokinase. A simple urokinase assay based on this phenomenon.
Ambrus CM; Bartfay-Szabo A; Mirand E; Ambrus JL
Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):339-47. PubMed ID: 461988
[TBL] [Abstract][Full Text] [Related]
10. [Role of single chain pro-UK on the initiation and regulation of fibrinolysis].
Arimura H; Kasai S; Nishida M; Suyama T
Rinsho Byori; 1989 Apr; Spec No 81():107-17. PubMed ID: 2502639
[No Abstract] [Full Text] [Related]
11. Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinase.
Wojta J; Kirchheimer JC; Turcu L; Christ G; Binder BR
Thromb Haemost; 1986 Jun; 55(3):347-51. PubMed ID: 3092391
[TBL] [Abstract][Full Text] [Related]
12. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology.
Zamarron C; Lijnen HR; Van Hoef B; Collen D
Thromb Haemost; 1984 Aug; 52(1):19-23. PubMed ID: 6495259
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a recombinant chimeric plasminogen activator composed of Gly-Pro-Arg-Pro tetrapeptide and truncated urokinase-type plasminogen activator expressed in Escherichia coli.
Hua ZC; Chen XC; Dong C; Zhu DX
Biochem Biophys Res Commun; 1996 May; 222(2):576-83. PubMed ID: 8670247
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of placental plasminogen activator (PPA).
Kobayashi T; Terao T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):783-92. PubMed ID: 3923141
[TBL] [Abstract][Full Text] [Related]
15. Changes in pericardial morphology and fibrinolytic activity during cardiopulmonary bypass.
Nkere UU; Whawell SA; Thompson EM; Thompson JN; Taylor KM
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):339-45. PubMed ID: 8341074
[TBL] [Abstract][Full Text] [Related]
16. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
Castañon MM; Gamba C; Kordich LC
Thromb Res; 2007; 120(5):745-52. PubMed ID: 17270255
[TBL] [Abstract][Full Text] [Related]
17. Immunological characterization of plasminogen activator activities in human tissues and body fluids.
Rijken DC; Wijngaards G; Welbergen J
J Lab Clin Med; 1981 Apr; 97(4):477-86. PubMed ID: 6782183
[TBL] [Abstract][Full Text] [Related]
18. Effects of wine on plasma fibrinolytic and coagulation systems.
Sumi H; Kozaki Y; Yatagai C; Hamada H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 1998 Jun; 33(3):263-72. PubMed ID: 9702004
[TBL] [Abstract][Full Text] [Related]
19. Effect of furosemide on plasma fibrinolytic activity and urokinase excretion.
Chohan IS; Singh I; Vermylen J; Verstraete M
Exp Hematol; 1977 Mar; 5(2):153-7. PubMed ID: 844519
[TBL] [Abstract][Full Text] [Related]
20. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
Guimarães AH; Rijken DC
Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
